MedTrace Logo

Protocol for Post Marketing Surveillance of Actilyse Vial

NCT02229799 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 265

Last updated 2014-09-01

No results posted yet for this study

Summary

The objectives of this study are to review the safety and efficacy of Actilyse Vial (hereafter referred to as "Actilyse") in post-marketing use for treatment of acute ischemic stroke, through investigating followings;

1. Unknown adverse events (especially serious adverse events)
2. Frequency (Incidence) and trend of adverse events under the actual practice
3. Factors on the safety profile of Actilyse
4. Factors on the efficacy profile of Actilyse

Conditions

Interventions

DRUG

Actilyse

Sponsors & Collaborators

Eligibility

Min Age
19 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-28
Primary Completion
2004-12-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02229799 on ClinicalTrials.gov